Product Reports Resources Pricing Login Book a demo

SOLASTA Bio

Food · Glasgow, United Kingdom · Founded 2020

Nature-inspired, peptide-based bioinsecticides for targeted pest control MoreLess

SOLASTA Bio is a UK-based agricultural biotechnology company developing a new generation of green insecticides. Founded in 2020 as a spin-out from the University of Glasgow by Professor Shireen Davies, Professor Julian Dow, and Paul Bernasconi, the company is built on four years of prior research. Davies, who serves as CEO, has a background in insect neuroendocrinology, while CSO Julian Dow is an expert in insect biology and functional genomics.

The company has created the world's first technology platform for developing neuropeptide-based insect control agents (ICAs). Unlike traditional synthetic chemical pesticides, SOLASTA Bio's products are nature-inspired and derived from peptides that are integral to an insect's metabolism. This allows for a highly specific mode of action that targets physiological functions in pest insects while remaining non-toxic to beneficial species like pollinators, as well as to humans and the wider environment. The products are biodegradable and do not accumulate in nature. This approach addresses key market challenges such as widespread insect resistance to chemical pesticides and the negative ecological impact of conventional crop protection methods.

SOLASTA Bio's business model centers on the development and commercialization of these proprietary bioinsecticides. The company targets the global agricultural industry, providing growers with a safer and more sustainable alternative for crop protection that has demonstrated efficacy on par with or better than commercial standards in multiple field trials. Its platform can be adapted for any pest of interest across both crop and non-crop applications, such as stored grain. The company has raised a total of $19 million, including a $14 million Series A round in September 2024, with investors like Forbion, FMC Ventures, and Corteva Catalyst. This funding is aimed at accelerating development, scaling up manufacturing, expanding US operations from its North Carolina base, and preparing for a targeted market entry by 2027.

Keywords: bioinsecticides, peptide-based pest control, agritech, crop protection, sustainable agriculture, neuropeptides, green insecticides, pollinator safety, biological pesticides, pest management, agricultural biotechnology, food security, insect control agents, venture capital, University of Glasgow spin-out, biopesticides, crop science, sustainable farming, non-toxic pesticides, biodiversity preservation

Company overview

SOLASTA Bio company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
Glasgow, United Kingdom
Employees
38
Open positions
None listed
Dealroom signal
81.2
client focusb2btechnologyHardwaretechnologyDeep Techsub industryAgriTechbusiness modelManufacturingsectorBiotechnologysectorPest ControlsectorBiopesticidessectorPesticidessectorSpinoutsectorSustainable Development GoalssectorRegenerative AgriculturesectorBiotechnology in FoodsectorClimate Tech

Valuation & funding

SOLASTA Bio funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Sep 2024 $14M $56M SIS Ventures · University of Glasgow · Cavallo Ventures · Forbion Capital Partners
GRANTOther financing Mar 2024 $1M UPL
GRANTOther financing Apr 2023 Scottish Enterprise Growth Investments · UK Research and Innovation
SEEDEquity / VC Apr 2023 $5.3M $21M Scottish Enterprise Growth Investments · Rubio Impact Ventures · Future Planet Capital · The Yield Lab
GRANTOther financing Aug 2022 $1.5M Undisclosed
SEEDEquity / VC Aug 2021 Future Planet Capital · The Yield Lab · SIS Ventures · Scottish Enterprise Growth Investments
SEEDEquity / VC Jan 2021 Scottish Enterprise Growth Investments · Future Planet Capital
SPINOUTOther financing May 2020 University of Glasgow
Showing 8 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 38
2025 39
2024 29
2023 30
2022 18
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

SOLASTA Bio website traffic

Latest recorded traffic for SOLASTA Bio is 90 monthly website visits, down 94.7% over the last three months. SOLASTA Bio's team declined 2.6% over the past year.

Latest monthly visits90 3-month web change-94.7% 1-year team growth-2.6%
Monthly website visits38 observations · Sep 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

SOLASTA Bio compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

SOLASTA Bio's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on SOLASTA Bio's cap table

Sourced from Dealroom's funding and investor records.

Seed 8 investors entered at this stage
Future Planet Capital
Scottish Enterprise Growth Investments
The Yield Lab
SIS Ventures
UK Research and Innovation
Rubio Impact Ventures
Cavallo Ventures
UPL
Series A 3 investors entered at this stage
Forbion Capital Partners
Corteva
University of Glasgow
Other known 2 additional known investors
StartLife
The Yield Lab Europe

Global footprint

Where SOLASTA Bio has talent and traffic

Workforce by country
3 countries with
team presence
🇬🇧 United Kingdom68%
🇺🇸 United States24%
🇳🇱 Netherlands8%
3 countries shown

In the news

Latest news about SOLASTA Bio

Recent press, funding announcements, and product moves mentioning SOLASTA Bio — open to read from the original sources.

See all news

Market sentiment

What the market is saying about SOLASTA Bio

An AI-synthesized read of the highest-engagement posts about SOLASTA Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SOLASTA Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.